EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754)

NCT04515043 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: INVAC-1 given in the previous phase 1 NCT02301754. No new injection is required in this study.

Sponsor

Invectys